|
Encephalopathy Autoimmune Eval, S
ENS2
Synonyms
|
|
Allscripts (AEHR) Order Name
|
Encephalopathy Autoimmune Eval, S
|
Sunrise Clinical Manager (SCM) Order Name
|
Encephalopathy, Autoimmune Evaluation, Serum
|
EPIC Order Name
|
Encephalopathy, Autoimmune/Paraneoplastic Evaluation, Serum
|
Clinical Info
|
Mayo code ENS2
Evaluating new onset encephalopathy (noninfectious or metabolic) comprising confusional states, psychosis, delirium, memory loss, hallucinations, movement disorders, sensory or motor complaints, seizures, dyssomnias, ataxias, nausea, vomiting, inappropriate antidiuresis, coma, dysautonomias, or hypoventilation in serum specimens
The following accompaniments should increase of suspicion for autoimmune encephalopathy:
-Headache
-Autoimmune stigmata (personal or family history or signs of diabetes mellitus, thyroid disorder, vitiligo, poliosis [premature graying], myasthenia gravis, rheumatoid arthritis, systemic lupus erythematosus)
-History of cancer
-Smoking history (20+ pack years) or other cancer risk factors
-Inflammatory cerebral spinal fluid (or isolated protein elevation)
-Neuroimaging signs suggesting inflammation
Evaluating limbic encephalitis (noninfectious)
Directing a focused search for cancer
Investigating encephalopathy appearing in the course or wake of cancer therapy and not explainable by metastasis or drug effect
|
Specimen Type
|
Blood
|
Container
|
Red Top Tube
|
Collection Instructions
|
Container/Tube: Gold Top or Red Top Tube
Specimen: 4.0 mL serum (2.5 mL min)
Patient Preparation:
1. For optimal antibody detection, specimen collection is recommended prior to initiation of immunosuppressant medication or intravenous immunoglobulin treatment.
2. This test should not be requested in patients who have recently received radioisotopes, therapeutically or diagnostically, because of potential assay interference. The specific waiting period before specimen collection will depend on the isotope administered, the dose given, and the clearance rate in the individual patient. Specimens will be screened for radioactivity prior to analysis. Radioactive specimens received in the laboratory will be held 1 week and assayed if sufficiently decayed, or canceled if radioactivity remains.
3. Patient should have no general anesthetic or muscle-relaxant drugs in the previous 24 hours.
|
Transport Instructions
|
Refrigerated
|
Specimen Stability
|
72 Hours Room Temperature
28 Days Refrigerated or Frozen
|
Methodology
|
Indirect Immunofluorescence Assay (IFA)
Cell-Binding Assay (CBA)
Western Blot (WB)
Immunoblot (IB)
Radioimmunoassay (RIA)
|
Days Performed
|
TAT: 9-13 Days
|
Performing Laboratory
|
Mayo Clinic Laboratories in Rochester
|
CPT
|
86255 x 23
86341
LOINC Code: 94697-0
|
PDM
|
1759374
|
Result Interpretation
See Report
|
Forms
|
|
|